ANALOG Devices And Flagship Pioneering Reached Strategic Cooperation To Accelerate The Development Of The Development Of The Entire Digital Biological World

China, Beijing— July 29, 2024 -The world's world's leading semiconductor company Analog Devices, Inc. (NASDAQ: ADI) and biological platform innovation company Flagship Pioneering announced a strategic alliance to accelerate the development of the entire digital biological world.This cooperation will combine the expertise of ADI in the field of simulation and digital semiconductor engineering and Flagship Pioneering in the field of application biology to jointly promote the excavation of biological insights and new and enhanced measurement, diagnosis and new intervention measures.This cooperation brings rare opportunities to both parties, aiming to create breakthrough solutions for human health and sustainable development.

1.png

ADI CEO and Chairman of the Board of Directors Vincent Roche (left) and Flagship Pioneering founder and CEO Dr. Noubar Afeyan (right) (right)

existADI General Technology Conference (GTC) held at Boston, Massachusetts, Massachusetts, USA on April 25, 2024

Specifically, this cooperation will be combinedFlagship Pioneering's unique innovation process and ADI advanced semiconductor technology, signal processing product portfolio and professional knowledge in the physical world are developed to develop subversive solutions in the field of digital biology and create new companies.In the initial stage, we will focus on the innovative application of biological electronic platforms, renewable agriculture, AI/ML, and prevent health and medicine.The future progress may further promote the next generation of protein sequencing, multi -group research, early disease diagnosis, digital transformation of large -scale biological information, drug design and optimizationBreakthrough in the domain.This cooperation isFlagship Pioneering's latest measures in the technical plan, which is committed to developing new treatment methods by promoting the development of advanced technologies.

ADI CEO and Chairman of the Board of Directors Vincent Roche said that the core mission of ADI is to accelerate breakthrough innovation and make our lives and the world we live in a better.Innovative technology is expected to help us achieve better and more positive health care.We look forward to cooperating with Flagship Pioneering in the field of digital biology, so that smart marginal technology is placed in the core position of developing innovative data -driven health solutions to cope with some major challenges today.

2.png

Dr. Noubar Afeyan, the founder and CEO of Flagship Pioneering, said: With the promotion of technological leaps and profound understanding of biology, we have entered a new era of biomedical and life science innovation.Good human and earth health.Flagship and ADI have a common vision and complementary advantages. The two sides are committed to accelerating the development of the full digital biological world and using natural wisdom to create solutions to prevent and therapeutic drugs, regeneration agriculture, and respond to climate change challenges.

This cooperation will be causedFlagship pioneering has pushed and promotes innovative process promotion of new technologies and biological insights, and has brought new types of treatment methods such as mRNA, TRNA, and epigenetic regulation.The application of ADI in the fields of sensing technology, micro -processing technology and medical health automation (including diagnosis, imaging, treatment equipment and continuous monitoring) will support the combined innovation promoted by this cooperation.Flagship pioneering scientists and entrepreneurs will cooperate with ADI scientists and engineers to conceive and create new biological platforms. Relying on the platform to combine biology and technology, to promote innovation in the field of human health and sustainable development